higher order crossover methodology [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2020-06-30 18:17 (725 d 08:55 ago) – Posting: # 21623
Views: 3,222

Ah,

it is all coming together now.

Thanks sweiner,
this is a great question.:-)

» In a 5-way BE crossover trial, is there a methodology available that allows one to analyze 3 out of 5 sequences for BE in an interim fashion, and contingent upon results complete the remaining 2 sequences and analyze all 5 sequences at the conclusion?

Should read: "In a 5-way BE crossover trial, is there a methodology available that allows one to analyze 3 out of 5 periods for BE in an interim fashion, and contingent upon results complete the remaining 2 periods and analyze all 5 periods at the conclusion?"

This is an interesting idea, one that has not been explored much yet in the public domain; I think a few other sponsors have used it.
It is definitely doable as a single protocol. It is in fact what other companies / sponsors are achieving with two separate studies. Just do it, I think it may not require much operational adjustment or statistical fiddling, unless you can say you will switch to another formulation and re-start another 5-period trial once the first formulation fails after 3 periods.

A great post, in my opinion.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Sunday 03:12 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5